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Abstract
Background: Differentiated thyroid cancer is usually associated with an excellent prognosis and indolent course.
Distant metastases are rare events at the onset of thyroid cancer. Among these presentations, metastasis to the
axillary lymph nodes is even more unusual: only few cases were previously reported in the literature; there has
been no report of axillary lymph node metastasis from follicular thyroid carcinoma. Axillary lymph node metastasis
generally arises in the context of disseminated disease and carries an ominous prognosis.
Case presentation: Here we present a case of axillary lymph node metastasis in the context of disseminated
differentiated thyroid cancer. The patient underwent near total thyroidectomy and neck and axillary lymph node
dissection. A histopathological diagnosis of poorly differentiated follicular carcinoma with “signet ring cells” and
Hürthle cell features was established. The patient received radioactive iodine therapy and TSH suppression therapy.
Subsequently his serum thyroglobulin level decreased to 44.000 ng/ml from over 100.000 ng/ml.
Discussion and Conclusion: Currently there are only few reported cases of axillary node metastases from thyroid
cancer, and to our knowledge, this is the first report on axillary lymph node metastasis from follicular thyroid
carcinoma. “Signet ring cell” is a morphologic feature shared by both benign and, more rarely, malignant follicular
thyroid neoplasm, and it generally correlates with an arrest in folliculogenesis. Our case is one of the rare “signet
ring cells” carcinomas so far described.
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Background
Differentiated thyroid cancer is usually associated with
an excellent prognosis and indolent course. Distant
metastases are rare events at the onset of thyroid cancer.
Their incidence is about 4%, with an overall risk which
is lowest for papillary thyroid cancers (2%) and highest
for follicular (11%) and Hürthle cell carcinomas (12%)
[1]. Among these presentations, metastasis to the axil-
lary lymph nodes is even more unusual. It generally
arises in the context of disseminated disease and carries
an ominous prognosis [2]. Herein, we present the first
ever reported case of axillary lymph node metastasis
from follicular thyroid carcinoma. Interestingly this pre-
sentation was associated with peculiar histologic features
described, so far, only in four other cases of follicular-
derived thyroid carcinoma.
Case presentation
A 65-year-old man was referred on April 2010 to our
surgical department with histologically documented
metastatic thyroid carcinoma on biopsy samples taken
from a pathological fracture of his left femur. He had
already undergone orthopedic stabilization of the fracture
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Computed Tomography (CT) documented a tumor in
the right lobe of the thyroid, multiple cervical supraclavi-
cular and axillary lymph-nodes, multiple bone metastases
and liver metastasis (Figure 1). Aspiration biopsy cytology
of the neck and axillary lymph nodes showed malignant
thyroid follicular epithelium-derived cells. Levels of
serum thyroglobulin and anti-thyroglobulin antibodies
were 102815,0 ng/mL and 727,4 IU/ml, respectively.
We treated the primary thyroid tumour with a near-
total thyroidectomy including central plus right neck
dissection and the addition of right axillary lymph node
dissection.
On gross pathological examination, the thyroidectomy
specimen weighted 74 g; the right lobe was enlarged,
measuring 7.5 × 3.5 × 3 cm. The cutting surface showed
a solid nodule, 3.8 × 2.5 cm in size at the apex of the
right lobe. Microscopic examination of the thyroid
tumor showed a follicular neoplasm with two growth
patterns: micro- and macrofollicular areas alternating
with predominantly cribriform and solid/insular areas. A
thick, fibrous capsule was still evident around the
nodule although it was completely invaded by the
tumor; extensive vascular invasion, within and beyond
the tumor capsule, was also observed.
Histologically, the cuboid neoplastic cells had eosino-
philic cytoplasm; a striking feature was represented by
their frequent cytoplasmic vacuolization, with formation
of “signet ring cells” having prominent cytoplasmic
vacuoles with eccentric nuclei. Colloid-like material was
found in micro-macrofollicular areas; focal mucoid
secretion within glandular lumens and inside the “signet
ring” cells too was highlighted by mucicarmine and
Alcian-blue staining; 7/22 cervical lymph nodes, 5/23
axillary lymph nodes showed massive infiltration/total
substitution by a follicular cell derived carcinoma with
three peculiar cell types: 1) cylindrical, eosinophilic cells
with apical snouts, arranged in follicle-like structures; 2)
oxyphilic cells with abundant granular cytoplasm and
strong nuclear pleomorphism; 3) cuboid cells with vesi-
cular, round nuclei with deeply eosinophilic nucleoli,
nuclear pseudoinclusions and a focal papillary growth
pattern were also evident. Immunohistochemistry was
performed using a peroxidase-antiperoxidase complex
method. Neoplastic cells, both in the primary thyroid
tumour and in the lymph node metastases, showed
intense and diffuse staining for thyreoglobulin (TG) and
thyroid transcription factor (TTF-1), while carcino-
embryonic antigen (CEA) and CD15 stainings were
negative. In areas with solid growth, p53, bcl2 and E-
cadherin were intensively expressed, and a Ki 67 stain-
ing ratio of > 10% was found. A diagnosis of poorly dif-
ferentiated follicular carcinoma with “signet ring cells”
and Hürthle- cell features was made (Figure 2).
The disease stage according to the AJCC criteria was
IVc. The patient received 260 mCi of
131I in May 2010
and 260 mCi of
131 I in October 2010. Radioiodine whole
body scan performed after completion of treatment still
Figure 1 CT imaging in axial (a, b) and coronal (c) plane: Lymph node metastasis in the right axilla (arrowhead) and in the
supraclavicular fossa (arrow).
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later, the patient is alive with persistent, stable disease
and, on a background treatment with levotiroxine 150
mcg per day; TSH approaches 0.5 uIU/mL and thyroglo-
bulin has lowered to 44.000 ng/ml.
Discussion and Conclusion
Currently there are only few reported cases of metastases
to the axillary lymph nodes in patients with thyroid can-
cer and, to our knowledge, this is the first report on
metastasis to the axillary lymph nodes from follicular
thyroid carcinoma. In the previously published cases, the
primary tumours were mostly papillary thyroid carcino-
mas [2-9], and less frequently medullary thyroid carci-
noma [7], sclerosing mucoepidermoid carcinoma with
eosinophilia [10], mucin-producing poorly differentiated
adenocarcinoma [11] and muco-epidermoid carcinoma
[12]. In most of the previously reported cases, axillary
lymph node metastases occurred in the context of disse-
minated disease, almost always as late recurrence. In our
case it occurred at the presentation in the context of a
disseminated follicular thyroid carcinoma. Some authors
hypothesized that retrograde spread of the tumor into
the axilla could be related to the blockage of the cervical
lymphatic vessels by metastatic lymph nodes or by surgi-
cal manipulation [5]. This hypothesis seems consistent
with our case. In our patient, in fact, there was a massive
lymph nodes involvement of the neck levels IV and V.
The axillary fat is contiguous with that of the inferolateral
neck, so we hypothesize that the spread to the axillary
lymph nodes could be related to the obstruction of lym-
phatic vessels. Follicular thyroid cancer has a high pro-
pensity to invade blood vessels and show-up as distant
metastases, but the role of angiogenesis and lymphangio-
genesis in thyroid cancer pathogenesis has not been clari-
fied [13]. So, in the present case, it can’tb ee s t a b l i s h e d
Figure 2 a) H/E 20x: Solid, poorly differentiated areas with focal follicular differentiation and many signet ring-like cells; b) H/E 40x: In
axillary metastasis, follicular growth pattern was associated to pseudopapillary structures; more abundant oxyphilic cytoplasm and
strong nuclear pleomorphism were evident; c) Alcian blu 20x: Signet ring cells contained Alcian blu positive mucous secretion; d) H/E
40x; Signet ring-like cells.
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an hematogenous dissemination.
The pathological features of the neoplasm represent
the second interesting aspect of our case. Primary muci-
nous carcinoma of the thyroid is extremely rare [14]. In
the WHO classification, mucinous carcinoma of the
thyroid is defined as a tumor characterized by clusters
of neoplastic cells surrounded by extensive extracellular
mucin deposit. On the other hand, many thyroid neo-
plasms, such as follicular adenoma, may produce mostly
intracellular mucins, in particular the “signet ring cell”
variant; moreover mucus may be produced also by carci-
nomas of papillary, follicular, medullary and mucoepi-
dermoid subtypes. Mlynek identified mucin in 50% and
35% of papillary and follicular tumors, respectively, and
emphasized that mucin production by follicular-derived
tumors can be commoner than usually thought [15]. In
the current case, “signet ring cells” and mucin-produ-
cing areas were frequently found.
To date, only four cases have been reported of follicu-
lar-derived thyroid carcinomas which show signet ring
features: three by Schröder et al. [16] and one by Felle-
gara et al. in a poorly differentiated Hürthle cell carci-
noma [17]. In a previous report, Gherardi et al. has
presented convincing evidence that “signet ring cells”
contained altered or abnormal thyroglobulin [18]. Felle-
gara and Rosai [17] have reported how vacuoles result
from intracytoplasmic accumulation of thyroglobulin as
demonstrated by immunohistochemistry, while they
appear bordered by microvilli on electronic microscopy.
This may suggest that they are intracytoplasmic follicular
lumina rather than secretion vacuoles and represent the
morphologic expression of an arrest in folliculogenesis
[17,18].
In the present case, both thyroglobulin and mucoid
secretion were demonstrated in the “signet-ring cells”,
according to previous reports [16]. Interestingly, micro-
scopic examination of axillary metastases showed neo-
plastic cells with ample granular eosinophilic cytoplasm
and pleomorphic nuclei, the typical features of Hürthle
cell carcinomas, similarly to two previously reported
cases of “signet ring cells” carcinoma [16,17]; on the
other hand, the “signet ring cell” features, in our case,
were prominent in the primary thyroid tumor, while they
were lacking in metastases. “Signet-ring cells” are hence
to be considered a morphologic feature shared by both
benign and, more rarely, malignant follicular thyroid neo-
plasm, and probably reflect an arrest in folliculogenesis.
Our case is one of the rare “signet ring cells” carcinomas
so far described.
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